{"id":52,"date":"2017-06-29T11:26:23","date_gmt":"2017-06-29T09:26:23","guid":{"rendered":"https:\/\/www.degro.org\/ag-stereotaxie\/?page_id=52"},"modified":"2025-02-11T17:54:30","modified_gmt":"2025-02-11T16:54:30","slug":"practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery","status":"publish","type":"page","link":"https:\/\/www.degro.org\/ag-stereotaxie\/projekte\/practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery\/","title":{"rendered":"Practice guidelines"},"content":{"rendered":"<div id=\"pl-52\"><style scoped>#pg-52-0 .panel-grid-cell { float:none } #pl-52 .panel-grid-cell .so-panel { margin-bottom:30px } #pl-52 .panel-grid-cell .so-panel:last-child { margin-bottom:0px } #pg-52-0 { margin-left:-15px;margin-right:-15px } #pg-52-0 .panel-grid-cell { padding-left:15px;padding-right:15px } #panel-52-0-0-0 a { color:#009cd8 } @media (max-width:780px){ #pg-52-0 .panel-grid-cell { float:none;width:auto } #pl-52 .panel-grid , #pl-52 .panel-grid-cell {  } #pl-52 .panel-grid .panel-grid-cell-empty { display:none } #pl-52 .panel-grid .panel-grid-cell-mobile-last { margin-bottom:0px }  } <\/style><div class=\"panel-grid\" id=\"pg-52-0\" ><div class=\"panel-grid-cell\" id=\"pgc-52-0-0\" ><div class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" id=\"panel-52-0-0-0\" data-index=\"0\"><div class=\"so-widget-sow-editor so-widget-sow-editor-base\">\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2>Practice guidelines of the DEGRO working group radiosurgery and stereotactic radiotherapy<\/h2>\n<p><span id=\"DeltaPlaceHolderMain\">The DEGRO working group stereotactic radiotherapy &amp; radiosurgery received the mandate of the DEGRO board to develop practice guidelines on the evidence-based use and practice of stereotactic radiotherapy and radiosurgery. <\/span><\/p>\n<p>So far, five practice guidelines have been developed and published:<\/p>\n<ul>\n<li>Radiosurgery for brain metastases<\/li>\n<li>Stereotactic body radiotherapy for early stage NSCLC<\/li>\n<li>Stereotactic body radiotherapy for primary and secondary liver cancer<\/li>\n<li>Stereotactic body radiotherapy for primary renal cell cancer and pancreatic cancer<\/li>\n<li>Stereotactic body radiotherapy for ventricular tachycardia<\/li>\n<\/ul>\n<p><strong>Referenzen:<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li>Brunner TB, Boda-Heggeman J, B\u00fcrgy D, et al. <strong>Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery<\/strong>. Strahlenther Onkol. 2024; 200(9): 737-750.\u00a0<br \/>\n<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38997440\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38997440\/<\/a><\/li>\n<li>Gkika E, Kostyszyn D, Fechter T, et al. <strong>Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities.<\/strong> Strahlenther Onkol. 2023; 199(11):973-981.<br \/>\n<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37268767\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37268767\/<\/a><\/p>\n<\/li>\n<li>Brunner T. (2022)<strong> [A Story of hypofractionation and the \"Table on the Wall\"]<\/strong>. Strahlenther Onkol. 2022; 198(8): 759-760.\u00a0<br \/>\n<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35674815\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35674815\/<\/a><\/li>\n<li>Kraft J, Mayinger M, Willmann J, et al. <strong>Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology. <\/strong>J Neurooncol. 2021; 152(2): 395\u2013404.<br \/>\n<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7997832\/\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7997832\/<\/a><\/p>\n<\/li>\n<li>Krug D, Blanck O, Andratschke N et al. <strong>Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia. <\/strong>Heart Rhythm. 2021;18(12): 2137-2145.<br \/>\n<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34380072\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34380072\/<\/a><\/p>\n<\/li>\n<li>Gkika E, Tanadini-Lang S, Kirste S, et al. <strong>Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group \"Stereotactic Radiotherapy\" of the German Society for Radiation Oncology (DEGRO).<\/strong> Strahlenther Onkol. 2017;193(10):823-830.<br \/>\n<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28695316\">www.ncbi.nlm.nih.gov\/pubmed\/28695316<\/a><\/p>\n<\/li>\n<li>Panje C, Andratschke N, Brunner TB et al. <strong>Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy<\/strong>. Strahlenther Onkol 2016; 192: 875-885.<br \/>\n<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27778052\"> www.ncbi.nlm.nih.gov\/pubmed\/27778052<\/a><\/p>\n<\/li>\n<li>Sterzing F, Brunner TB, Ernst I et al. <strong>Stereotactic body radiotherapy for liver tumors : Principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy.<\/strong> Strahlenther Onkol 2014; 190: 872-881.<br \/>\n<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25091267\">www.ncbi.nlm.nih.gov\/pubmed\/25091267<\/a><\/p>\n<\/li>\n<li>Guckenberger M, Andratschke N, Alheit H et al. <strong>Definition of stereotactic body radiotherapy : Principles and practice for the treatment of stage I non-small cell lung cancer.<\/strong> Strahlenther Onkol 2014; 190: 26-33.<br \/>\n<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24052011\">www.ncbi.nlm.nih.gov\/pubmed\/24052011<\/a><\/p>\n<\/li>\n<li>Kocher M, Wittig A, Piroth MD et al.<strong> Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.<\/strong> Strahlenther Onkol 2014; 190: 521-532.<br \/>\n<a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24715242\">www.ncbi.nlm.nih.gov\/pubmed\/24715242<\/a><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>#pg-52-0 .panel-grid-cell { float:none } #pl-52 .panel-grid-cell .so-panel { margin-bottom:30px } #pl-52 .panel-grid-cell .so-panel:last-child { margin-bottom:0px } #pg-52-0 { margin-left:-15px;margin-right:-15px } #pg-52-0 .panel-grid-cell { padding-left:15px;padding-right:15px } #panel-52-0-0-0 a { color:#009cd8 } @media (max-width:780px){ #pg-52-0 .panel-grid-cell { float:none;width:auto } #pl-52 .panel-grid <\/p>\n","protected":false},"author":8,"featured_media":0,"parent":754,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/52"}],"collection":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/comments?post=52"}],"version-history":[{"count":16,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/52\/revisions"}],"predecessor-version":[{"id":54,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/52\/revisions\/54"}],"up":[{"embeddable":true,"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/pages\/754"}],"wp:attachment":[{"href":"https:\/\/www.degro.org\/ag-stereotaxie\/wp-json\/wp\/v2\/media?parent=52"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}